Online inquiry

IVTScrip™ mRNA-Human ARL5A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28644MR)

This product GTTS-WK28644MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARL5A protein. This product can be used in CD4+ cytotoxic T cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001037174.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 26225
UniProt ID Q9Y689
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL5A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28644MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK16127MR IVTScrip™ mRNA-Human ANKRD45, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD45
GTTS-WK20423MR IVTScrip™ mRNA-Human AHNAK2, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AHNAK2
GTTS-WK7478MR IVTScrip™ mRNA-Human AFAP1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA AFAP1
GTTS-WK28556MR IVTScrip™ mRNA-Human ARAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARAP1
GTTS-WK18543MR IVTScrip™ mRNA-Human ANLN, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANLN
GTTS-WK7738MR IVTScrip™ mRNA-Human ADGRE3, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADGRE3
GTTS-WK11053MR IVTScrip™ mRNA-Human ADIPOR1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ADIPOR1
GTTS-WK9209MR IVTScrip™ mRNA-Human ADAMTSL3, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTSL3
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →